Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Covid crawled date : 2021 - 03 - 15 save search
Fulgent Genetics Awarded Contract from CDC to Study Variants of COVID-19 Virus
Published: 2021-03-15 (Crawled : 23:00) - biospace.com/
FLGT | $20.935 1.82% 25K
|
Health Services
|
| O: 2.5%
H: 7.74%
C: 6.41%
covid genetic contract covid-19 awards
Comerica and Comerica Charitable Foundation to Further Aid Communities with $16 Million Investment for COVID-19 Relief in 2021
Published: 2021-03-15 (Crawled : 18:00) - prnewswire.com
CMA | $53.05 0.84% 340K
|
Finance
|
| O: -0.49%
H: 0.48%
C: -0.81%
covid
Aeterna Zentaris Announces Exclusive License Agreement and Research Contract with Julius-Maximilians-University Wuerzburg for Development of a Potential Oral Prophylactic Bacterial Vaccine Against COVID-19
Published: 2021-03-15 (Crawled : 16:00) - biospace.com/
AEZS | $1.97 0.73% 6K
|
Health Technology
|
| O: 15.25%
H: 27.94%
C: 11.03%
covid potential contract vaccine license research
Edesa Biotech Reaches Enrollment Milestone in COVID Study
Published: 2021-03-15 (Crawled : 16:00) - biospace.com/
EDSA | $4.38 1.5K
|
Health Technology
|
| O: 8.21%
H: 3.14%
C: -1.65%
covid biotech iot enroll milestone
First Participants Dosed in Phase 1 Study Evaluating mRNA-1283, Moderna’s Next Generation COVID-19 Vaccine
Published: 2021-03-15 (Crawled : 15:00) - biospace.com/
MRNA | News S | $107.81 3.21% 900K
|
Health Technology
|
| O: -0.16%
H: 5.18%
C: 5.04%
covid phase 1 vaccine phase 3 phase 2 covid-19
aTyr Pharma Announces Positive Biomarker Data from Phase 2 Clinical Trial of ATYR1923 Demonstrating Anti-Inflammatory Effects in COVID-19 Patients with Severe Respiratory Complications
Published: 2021-03-15 (Crawled : 15:00) - biospace.com/
LIFE | $1.67 1.83% 130K
|
Health Technology
|
| O: 4.41%
H: 1.42%
C: -5.39%
covid phase 2 positive respiratory trial biomarkers
Chief Medical Officer of electroCore, Inc. Peter Staats, M.D. Describes Potential At-Home Solutions to Reduce Common COVID-19 Symptoms
Published: 2021-03-15 (Crawled : 14:00) - biospace.com/
ECOR | $5.74 2.14% 4.5K
|
Health Technology
|
| O: 0.0%
H: 3.74%
C: 2.8%
covid potential
Adamis Pharmaceuticals Announces Tempol Reduces Lung Inflammation in the COVID-19 Challenged Hamster Model
Published: 2021-03-15 (Crawled : 14:00) - biospace.com/
ADMP | $0.7751 0.86% 2.6% 120K
|
Health Technology
|
| O: 12.5%
H: 0.85%
C: -3.42%
covid covid-19
ImmunityBio Announces Positive Interim Phase I Safety Data of hAd5 T-Cell COVID-19 Vaccine Candidate in Oral and Sublingual Formulations
Published: 2021-03-15 (Crawled : 14:00) - biospace.com/
IBRX | $5.335 8.0% 20M
|
Manufacturing
|
| O: 2.0%
H: 3.34%
C: -1.06%
positive t-cell vaccine covid
Global Clinical Laboratory Services Market Report 2021-2024: COVID-19 Highlighted the Threat Posed by Infectious Diseases, Role of Clinical Labs in Testing Infectious Diseases Grows in Importance
Published: 2021-03-15 (Crawled : 14:00) - prnewswire.com
LH M | $207.09 1.98% 250K
|
Health Services
|
| O: -0.08%
H: 0.84%
C: 0.6%
covid disease infectious disease test
Biotechs Step Up Development Activities as U.S. Government Prioritizes Availability Of COVID-19 Vaccines
Published: 2021-03-15 (Crawled : 13:00) - prnewswire.com
PFE | News A | $26.34 0.31% 7.7M
|
Health Technology
|
| O: 0.2%
H: 1.2%
C: 1.14%
JNJ | News | $149.575 0.31% 2.5M
|
Health Technology
|
| O: 0.09%
H: 0.57%
C: 0.42%
NVAX | $4.285 5.28% 1.6M
|
Health Technology
|
| O: 0.27%
H: 7.58%
C: 6.95%
MRNA | News S | $107.81 3.21% 900K
|
Health Technology
|
| O: -0.16%
H: 5.18%
C: 5.04%
BNTX | News | $89.015 1.14% 120K
|
Health Technology
|
| O: 0.69%
H: 4.0%
C: 3.74%
covid biotech vaccine iot covid-19
AdCOVID™, Altimmune’s Single Dose, Intranasal COVID-19 Vaccine Candidate, Prevents SARS-CoV-2-induced Disease and Blocks Viral Replication in Preclinical Studies of SARS-CoV-2 Infection
Published: 2021-03-15 (Crawled : 13:00) - biospace.com/
ALT | $8.0 7.1% 1.2M
|
Commercial Services
|
| O: 2.74%
H: 5.87%
C: 2.96%
covid disease adcovid vaccine injection preclinical sars-cov-2 pre-clinical infections
Takeda and IDT Support Manufacturing of Johnson & Johnson’s COVID-19 Vaccine
Published: 2021-03-15 (Crawled : 13:00) - biospace.com/
TAK | News | $13.4 0.3% 790K
|
Health Technology
|
| O: 1.36%
H: 1.12%
C: 0.96%
JNJ | News | $149.575 0.31% 2.5M
|
Health Technology
|
| O: 0.09%
H: 0.57%
C: 0.42%
covid vaccine covid-19
Global Antifreeze Market Forecast to 2027 - COVID-19 Impact and Analysis
Published: 2021-03-15 (Crawled : 12:00) - prnewswire.com
XOM | $120.35 -0.17% 3.3M
|
Energy Minerals
|
| O: -0.77%
H: 0.59%
C: -1.79%
CTS | News | $44.29 1.19% 18K
|
Electronic Technology
|
| O: -0.33%
H: 0.0%
C: -0.54%
CVX | $161.38 -0.33% 1M
|
Energy Minerals
|
| O: -0.03%
H: 0.34%
C: -1.15%
BP | $38.925 0.04% 2.6M
|
Energy Minerals
|
| O: -0.96%
H: 0.51%
C: -0.79%
covid covid-19
Molecular Partners and Novartis Announce Inclusion of COVID-19 Antiviral Candidate, ensovibep, in NIH-Sponsored ACTIV-3 Trial
Published: 2021-03-15 (Crawled : 10:00) - biospace.com/
NVS | News | $97.63 2.64% 1.6M
|
Health Technology
|
| O: 0.25%
H: 1.17%
C: 1.13%
covid antiviral molecular trial ensovibep
Global Food Preservatives Market Procurement Intelligence Report with COVID-19 Impact Analysis | Global Market Forecasts, Analysis 2021-2025 | SpendEdge
Published: 2021-03-15 (Crawled : 08:00) - prnewswire.com
UNVR | $36.14 0.47% 0.0% 0
|
Distribution Services
|
| O: 0.33%
H: 0.32%
C: 0.09%
covid food
Gainers vs Losers
| 87% | 13% |
Top 10 Gainers
MTTR | News M | $4.595 164.08% 13M
|
AGBA | $2.355 88.4% 34M
|
Finance
EDBL | News | $6.75 79.52% 1.5M
|
CZOO | $8.77 75.75% 11M
|
MTC | $2.28 46.15% 2.6M
|
Technology Services
OPRT | News | $3.14 39.56% 7.6M
|
Finance
VNRX | $0.8 33.33% 2.9M
|
Health Technology
MLEC | $1.865 33.21% 2.4M
|
n/a
PALI | $6.37 29.21% 21M
|
Manufacturing
CMAX | $4.12 28.35% 65K
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.